Latest Federal Register Notices

Public Meeting Planned on Alopecia Drug Development
Federal Register notice: FDA announces a 9/11 public meeting on “Patient-Focused Drug Development for Alopecia Areata.” 06/23/2017

Nominations Sought for Device GMP Panel Members
Federal Register notice: CDRH seeks nominations for voting members to serve on the Device Good Manufacturing Practice Advisory Committee and device panels of the Medical Devices Advisory Committee. 06/23/2017

Comments Sought on Continuous Manufacturing Proposal
Federal Register notice: FDA seeks comments on a submission involving proposed recommendations for industry on developing continuous manufacturing for solid dosage drug products. 06/23/2017

FDA Withdraws 121 NDAs, 161 ANDAs
Federal Register notice: FDA withdraws approval of 121 NDAs and 161 ANDAs from multiple applicants. 06/22/2017

Public Meeting on Hatch-Waxman Amendments
Federal Register notice: FDA announces a 7/18 public meeting on “‘The Hatch-Waxman Amendments: Ensuring a Balance Between Innovation and Access.” 06/22/2017

Comments Sought on FDA Fellowship Applications
Federal Register notice: FDA seeks comments on an information collection extension for “Application for Participation in FDA Fellowship Programs.” 06/21/2017

Comments Sought for Rapid Response Surveys
Federal Register notice: FDA seeks comments on an information collection extension for “FDA Rapid Response Surveys OMB Control Number 0910–0500.”06/21/2017